TROYANOSYVIRUS
Back to CVEs

CVE-2025-31251

MEDIUM
5.5

Description

The issue was addressed with improved input sanitization. This issue is fixed in iOS 18.5 and iPadOS 18.5, iPadOS 17.7.7, macOS Sequoia 15.5, macOS Sonoma 14.7.6, macOS Ventura 13.7.6, tvOS 18.5, visionOS 2.5, watchOS 11.5. Processing a maliciously crafted media file may lead to unexpected app termination or corrupt process memory.

CVE Details

CVSS v3.1 Score5.5
SeverityMEDIUM
CVSS VectorCVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:N/A:N
Attack VectorLOCAL
ComplexityLOW
Privileges RequiredNONE
User InteractionREQUIRED
Published5/12/2025
Last Modified4/2/2026
Sourcenvd
Honeypot Sightings0

Affected Products

apple:ipadosapple:iphone_osapple:macosapple:tvosapple:visionosapple:watchos

Weaknesses (CWE)

CWE-400

References

https://support.apple.com/en-us/122404(product-security@apple.com)
https://support.apple.com/en-us/122405(product-security@apple.com)
https://support.apple.com/en-us/122716(product-security@apple.com)
https://support.apple.com/en-us/122717(product-security@apple.com)
https://support.apple.com/en-us/122718(product-security@apple.com)
https://support.apple.com/en-us/122720(product-security@apple.com)
https://support.apple.com/en-us/122721(product-security@apple.com)
https://support.apple.com/en-us/122722(product-security@apple.com)
http://seclists.org/fulldisclosure/2025/May/11(af854a3a-2127-422b-91ae-364da2661108)
http://seclists.org/fulldisclosure/2025/May/12(af854a3a-2127-422b-91ae-364da2661108)
http://seclists.org/fulldisclosure/2025/May/5(af854a3a-2127-422b-91ae-364da2661108)
http://seclists.org/fulldisclosure/2025/May/6(af854a3a-2127-422b-91ae-364da2661108)
http://seclists.org/fulldisclosure/2025/May/7(af854a3a-2127-422b-91ae-364da2661108)
http://seclists.org/fulldisclosure/2025/May/8(af854a3a-2127-422b-91ae-364da2661108)
http://seclists.org/fulldisclosure/2025/May/9(af854a3a-2127-422b-91ae-364da2661108)

IOC Correlations

No correlations recorded

This product uses data from the NVD API but is not endorsed or certified by the NVD.